From left to right: Jesse Christopher (CEO, Longeviti Neuro Solutions), Brad Hennessie (CEO, NextStep Robotics), Deborah Hemingway (Managing Partner, Ecphora Capital), Steve Schaefer (CEO, Mi-Helper), Andrea Pais (CEO, Novel Microdevices) Maryland’s [….]
Baltimore, MD is continuing to emerge as one of the next great cities for medtech and medical device innovation. That’s just one of the reasons that Maryland was selected to host MedTech Innovator (MTI) and BioTools Innovator (BTI) for their East Coast pitch events on March 28-31, 2023. MTI and BTI are the largest and highest-performing global pitch competitions and accelerator programs for the life sciences field. Companies can apply before January 31st.
Haystack Oncology and Longeviti Neuro Solutions, life science companies affiliated with Johns Hopkins University, have signed leases at City Garage Science and Technology Center totaling over 30,000 square feet in Baltimore Peninsula. Additionally, Launchport has expanded their operations by 6,200-sf.
Longeviti Neuro Solutions, developer of the first low-profile intracranial devices that meets the functional and reconstructive needs of brain surgery patients, recently announced that it was granted a 510(k) clearance by the U.S Food and Drug Administration (FDA) for ClearFit® OTS (off-the-shelf).
Longeviti Neuro Solutions, developer of the first low-profile intracranial devices that meet the functional and reconstructive needs of brain surgery patients, has hired Dr. David Langer as chief medical officer. With more than 22 years of experience in highly personalized direct patient care and expertise in medical technology, Dr. Langer will develop and drive the clinical strategy to expand use of Longeviti’s innovative solutions for patients undergoing complex brain surgery.
Longeviti FDA-cleared neuro surgical implants – the ClearFit and the InvisiShunt
